7 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 7 of 7 clinical reviews.
A clinical comparison of berberine vs. metformin: shared mechanism, what trial evidence actually shows, A1C and glucose targets, dangerous thresholds, and the dawn phenomenon, with an evidence-boundary map.
Evidence-based glipizide guide covering immediate- and extended-release dosing, hypoglycemia, kidney considerations, and accurate comparisons with common diabetes medicines.
GLP-1 drugs can trigger low blood sugar 2-4 hours after eating by amplifying insulin release. Learn causes, symptoms, the MMTT test, and treatment options.
A guide to metformin-associated lactic acidosis (MALA): real incidence rates, who is at risk, FDA contraindications, drug interactions, and when to hold or stop the drug safely.
Learn how to titrate metformin safely, manage GI side effects, and understand how it fits into basal-bolus insulin regimens, carb counting, and insulin-to-carb ratio calculations.
A comparison of metformin and GLP-1 receptor agonists covering mechanism, efficacy, weight loss, cardiovascular outcomes, side effects, cost, and when to use each drug or both together.
Complete clinical guide to pioglitazone (Actos) for type 2 diabetes: mechanism, dosing, side effects, cardiovascular data, and head-to-head comparisons with metformin, glipizide, empagliflozin, and dapagliflozin.
LegitScript certification
Verify HealthRX.comHealthRX.com is a platform connecting patients with independent licensed healthcare providers and pharmacies. Those providers deliver medical care and pharmacies dispense medication. Prescriptions are issued only when clinically appropriate. Payment does not guarantee a prescription.
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Individual results vary.
Website information is educational and is not a substitute for personalized medical advice, diagnosis, or treatment. Consult your licensed healthcare provider.